8-K

Company

Spyre Therapeutics, Inc.

Filed

February 19, 2026

Period of Report

February 19, 2026

Accession Number

0001636282-26-000022

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →